M. Andrykowski, M. Bishop, E. Hahn, D. Cella, J. Beaumont et al., Long-Term Health-Related Quality of Life, Growth, and Spiritual Well-Being After Hematopoietic Stem-Cell Transplantation, Journal of Clinical Oncology, vol.23, issue.3, pp.599-608, 2005.
DOI : 10.1200/JCO.2005.03.189

M. Tremolada, S. Bonichini, M. Pillon, C. Messina, and M. Carli, Quality of life and psychosocial sequelae in children undergoing hematopoietic stem-cell transplantation: A review, Pediatric Transplantation, vol.79, issue.Suppl. 3, pp.955-70, 2009.
DOI : 10.1080/1363849021000064553

K. Baker, K. Ness, D. Weisdorf, L. Francisco, C. Sun et al., Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study, Leukemia, vol.67, issue.12, pp.2039-2086, 2010.
DOI : 10.1182/blood-2006-02-003954

G. Socié, N. Salooja, A. Cohen, A. Rovelli, E. Carreras et al., Nonmalignant late effects after allogeneic stem cell transplantation, Blood, vol.101, issue.9, pp.3373-85, 2003.
DOI : 10.1182/blood-2002-07-2231

C. Sun, J. Kersey, L. Francisco, S. Armenian, K. Baker et al., Burden of Morbidity in 10+ Year Survivors of Hematopoietic Cell Transplantation: Report from the Bone Marrow Transplantation Survivor Study, Biology of Blood and Marrow Transplantation, vol.19, issue.7, pp.1073-80, 2013.
DOI : 10.1016/j.bbmt.2013.04.002

J. Berbis, G. Michel, P. Chastagner, N. Sirvent, F. Demeocq et al., A French Cohort of Childhood Leukemia Survivors: Impact of Hematopoietic Stem Cell Transplantation on Health Status and Quality of Life, Biology of Blood and Marrow Transplantation, vol.19, issue.7, pp.1065-72
DOI : 10.1016/j.bbmt.2013.04.015

L. Madden, A. Ngwube, S. Shenoy, T. Druley, and R. Hayashi, Late Toxicity of a Novel Allogeneic Stem Cell Transplant Using Single Fraction Total Body Irradiation for Hematologic Malignancies in Children, Journal of Pediatric Hematology/Oncology, vol.37, issue.2, pp.94-101
DOI : 10.1097/MPH.0000000000000272

C. Dvorak, C. Gracia, J. Sanders, E. Cheng, K. Baker et al., PBMTC First International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Endocrine Challenges--Thyroid Dysfunction, Growth Impairment, Bone Health, & Reproductive Risks. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant, 2011.

F. Orio, G. Muscogiuri, S. Palomba, B. Serio, M. Sessa et al., Endocrinopathies after Allogeneic and Autologous Transplantation of Available from, Hematopoietic Stem Cells. Sci World J [Internet], p.2014, 2014.

W. Leung, H. Ahn, S. Rose, S. Phipps, T. Smith et al., A prospective cohort study of late sequelae of pediatric allogeneic hematopoietic stem cell transplantation. Medicine (Baltimore), pp.215-239, 2007.

E. De-berranger, G. Michel, M. Fahd, V. Gandemer, C. Jubert et al., Prise en charge des s??quelles apr??s greffe de cellules souches h??matopo????tiques chez l???enfant??: recommandations de la SFGM-TC, Pathologie Biologie, vol.62, issue.4, pp.212-219, 2014.
DOI : 10.1016/j.patbio.2014.05.009

L. Tauchmanovà, C. Selleri, G. Rosa, L. Pagano, F. Orio et al., High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases. Cancer, pp.1076-84, 2002.

E. Chow, D. Friedman, M. Stovall, Y. Yasui, J. Whitton et al., Risk of thyroid dysfunction and subsequent thyroid cancer among survivors of acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study, Pediatric Blood & Cancer, vol.90, issue.3, pp.432-439, 2009.
DOI : 10.1016/S0360-3016(98)00222-3

W. Chemaitilly and C. Sklar, Endocrine complications in long-term survivors of childhood cancers, Endocrine Related Cancer, vol.17, issue.3, pp.141-59, 2010.
DOI : 10.1677/ERC-10-0002

A. Cohen, A. Békássy, A. Gaiero, M. Faraci, S. Zecca et al., Endocrinological late complications after hematopoietic SCT in children, Bone Marrow Transplantation, vol.15, issue.2, pp.43-51, 2008.
DOI : 10.1111/j.1399-3046.2006.00498.x

M. Vantyghem, J. Cornillon, C. Decanter, F. Defrance, W. Karrouz et al., Management of endocrino-metabolic dysfunctions after allogeneic hematopoietic stem cell transplantation, Orphanet Journal of Rare Diseases, vol.87, issue.2, p.162, 2014.
DOI : 10.1097/TP.0b013e318198d7d0

B. Savani, E. Koklanaris, Q. Le, A. Shenoy, S. Goodman et al., Prolonged Chronic Graft-versus-Host Disease is a Risk Factor for Thyroid Failure in Long-Term Survivors After Matched Sibling Donor Stem Cell Transplantation for Hematologic Malignancies, Biology of Blood and Marrow Transplantation, vol.15, issue.3, pp.377-81, 2009.
DOI : 10.1016/j.bbmt.2008.11.032

C. Oudin, P. Auquier, Y. Bertrand, P. Chastagner, J. Kanold et al., Late thyroid complications in survivors of childhood acute leukemia. An L.E.A. study, Haematologica, vol.101, issue.6, 2016.
DOI : 10.3324/haematol.2015.140053

URL : https://hal.archives-ouvertes.fr/hal-01482527

K. Baker, T. Defor, L. Burns, N. Ramsay, J. Neglia et al., New Malignancies After Blood or Marrow Stem-Cell Transplantation in Children and Adults: Incidence and Risk Factors, Journal of Clinical Oncology, vol.21, issue.7, pp.1352-1360, 2003.
DOI : 10.1200/JCO.2003.05.108

S. Bomken and R. Skinner, Secondary Malignant Neoplasms Following Haematopoietic Stem Cell Transplantation in Childhood, Children, vol.24, issue.2, pp.146-73, 2015.
DOI : 10.1016/j.blre.2010.03.002

A. Schneider, R. E. Lubin, J. Stovall, M. Gierlowski, and T. , Dose-response relationships for radiation-induced thyroid cancer and thyroid nodules: evidence for the prolonged effects of radiation on the thyroid, J Clin Endocrinol Metab, vol.77, issue.2, pp.362-371, 1993.

A. Cohen, A. Rovelli, D. Merlo, M. Van-lint, E. Lanino et al., Risk for Secondary Thyroid Carcinoma After Hematopoietic Stem-Cell Transplantation: An EBMT Late Effects Working Party Study, Journal of Clinical Oncology, vol.25, issue.17, pp.2449-54, 2007.
DOI : 10.1200/JCO.2006.08.9276

P. Bhatti, L. Veiga, C. Ronckers, A. Sigurdson, M. Stovall et al., Risk of Second Primary Thyroid Cancer after Radiotherapy for a Childhood Cancer in a Large Cohort Study: An Update from the Childhood Cancer Survivor Study, Radiation Research, vol.174, issue.6a, pp.741-52, 2010.
DOI : 10.1667/RR2240.1

L. Veiga, J. Lubin, H. Anderson, F. De-vathaire, M. Tucker et al., A Pooled Analysis of Thyroid Cancer Incidence Following Radiotherapy for Childhood Cancer, Radiation Research, vol.178, issue.4, 2012.
DOI : 10.1667/RR2889.1.S1

M. Wijnen, M. Van-den-heuvel-eibrink, M. Medici, R. Peeters, A. Van-der-lely et al., Risk factors for subsequent endocrine-related cancer in childhood cancer survivors, Endocrine-Related Cancer, vol.23, issue.6, pp.299-321
DOI : 10.1530/ERC-16-0113

A. Khalil, I. Zaidman, R. Bergman, R. Elhasid, and M. Ben-arush, Autoimmune Complications after Hematopoietic Stem Cell Transplantation in Children with Nonmalignant Disorders, The Scientific World Journal, vol.138, issue.7, p.581657, 2014.
DOI : 10.1056/NEJM199409013310903

A. Bacigalupo, K. Ballen, D. Rizzo, S. Giralt, H. Lazarus et al., Defining the Intensity of Conditioning Regimens: Working Definitions, Biology of Blood and Marrow Transplantation, vol.15, issue.12, pp.1628-1661, 2009.
DOI : 10.1016/j.bbmt.2009.07.004

S. Slavin, A. Nagler, E. Naparstek, Y. Kapelushnik, M. Aker et al., Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases, Blood. Feb, vol.191, issue.3, pp.756-63, 1998.

D. Blaise, N. Vey, C. Faucher, and M. Mohty, Current status of reduced intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia, Haematologica, vol.92, issue.4, 2007.
DOI : 10.3324/haematol.10867

A. Gratwohl, H. Baldomero, J. Passweg, and A. Urbano-ispizua, Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity survey, Bone Marrow Transplantation, vol.30, issue.12, pp.813-844, 2002.
DOI : 10.1038/sj.bmt.1703819

K. Rao, P. Amrolia, A. Jones, C. Cale, P. Naik et al., Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen, Blood, vol.105, issue.2, pp.879-85, 2005.
DOI : 10.1182/blood-2004-03-0960

B. Horn, L. Baxter-lowe, L. Englert, A. Mcmillan, M. Quinn et al., Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant disorders and CML, Bone Marrow Transplantation, vol.35, issue.3, pp.263-272, 2006.
DOI : 10.1038/sj.bmt.1705240

K. Straathof, K. Rao, M. Eyrich, G. Hale, P. Bird et al., Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 1/2 study, The Lancet, vol.374, issue.9693, pp.912-932, 2009.
DOI : 10.1016/S0140-6736(09)60945-4

P. Satwani, N. Cooper, K. Rao, P. Veys, and P. Amrolia, Reduced intensity conditioning and allogeneic stem cell transplantation in childhood malignant and nonmalignant diseases, Bone Marrow Transplantation, vol.17, issue.2, pp.173-82, 2008.
DOI : 10.1038/sj.bmt.1703777

S. Slavin, M. Aker, M. Shapira, I. Resnick, M. Bitan et al., Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders, Clin Transpl, pp.275-82, 2003.

J. Cornillon, M. Vantyghem, M. Couturier, E. De-berranger, S. François et al., Suivi et prise en charge des troubles endocriniens en post-greffe de cellules souches h??matopo????tiques??: dyslipid??mie et thyropathie, Pathologie Biologie, vol.61, issue.4, pp.168-70, 2013.
DOI : 10.1016/j.patbio.2013.07.010

C. Berger, B. Le-gallo, J. Donadieu, O. Richard, A. Devergie et al., Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukaemia, Bone Marrow Transplantation, vol.28, issue.10, pp.991-996, 2005.
DOI : 10.1038/jcbfm.1995.8

M. Slatter, A. Gennery, T. Cheetham, A. Bhattacharya, B. Crooks et al., Thyroid dysfunction after bone marrow transplantation for primary immunodeficiency without the use of total body irradiation in conditioning, Bone Marrow Transplantation, vol.33, issue.9, pp.949-53, 2004.
DOI : 10.1038/sj.bmt.1704456

G. Michel, G. Socié, F. Gebhard, F. Bernaudin, I. Thuret et al., Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation--a report from the Soci??t?? Fran??aise de Greffe de Moelle., Journal of Clinical Oncology, vol.15, issue.6, 1997.
DOI : 10.1200/JCO.1997.15.6.2238

J. Sanders, P. Hoffmeister, A. Woolfrey, P. Carpenter, B. Storer et al., Thyroid function following hematopoietic cell transplantation in children: 30 years' experience, Blood, vol.113, issue.2, pp.306-314, 2009.
DOI : 10.1182/blood-2008-08-173005

H. Bailey, M. Kappy, R. Giller, and J. Gralla, Time-course and risk factors of hypothyroidism following allogeneic hematopoietic stem cell transplantation (HSCT) in children conditioned with fractionated total body irradiation, Pediatric Blood & Cancer, vol.28, issue.3, pp.405-414, 2008.
DOI : 10.1016/S0360-3016(00)01373-0

E. Katsanis, R. Shapiro, L. Robison, R. Haake, T. Kim et al., Thyroid dysfunction following bone marrow transplantation: long-term follow-up of 80 pediatric patients, Bone Marrow Transplant, vol.5, issue.5, pp.335-375, 1990.

L. Madden, R. Hayashi, K. Chan, M. Pulsipher, D. Douglas et al., Long-Term Follow-Up after Reduced-Intensity Conditioning and Stem Cell Transplantation for Childhood Nonmalignant Disorders, Biology of Blood and Marrow Transplantation, vol.22, issue.8, pp.1467-72, 2016.
DOI : 10.1016/j.bbmt.2016.04.025

K. Mahadeo, K. Weinberg, H. Abdel-azim, D. Miklos, R. Killen et al., A Reduced-Toxicity Regimen Is Associated with Durable Engraftment and Clinical Cure of Nonmalignant Genetic Diseases among Children Undergoing Blood and Marrow Transplantation with an HLA-Matched Related Donor, Biology of Blood and Marrow Transplantation, vol.21, issue.3, 2015.
DOI : 10.1016/j.bbmt.2014.11.005

K. Myers, J. Howell, G. Wallace, C. Dandoy, J. El-bietar et al., Poor growth, thyroid dysfunction and vitamin D deficiency remain prevalent despite reduced intensity chemotherapy for hematopoietic stem cell transplantation in children and young adults, Bone Marrow Transplantation, vol.35, issue.7, 2016.
DOI : 10.1038/sj.bmt.1704853

S. Lee and A. Farwell, Euthyroid Sick Syndrome, Compr Physiol, vol.106, issue.2, pp.1071-80, 2016.
DOI : 10.1161/01.CIR.0000025587.40373.75

G. Van-den-berghe, Non-thyroidal illness in the ICU: a syndrome with different faces. Thyroid Off J Am Thyroid Assoc, pp.1456-65, 2014.

M. Toubert, G. Socié, E. Gluckman, S. Aractingi, H. Espérou et al., Short- and long-term follow-up of thyroid dysfunction after allogeneic bone marrow transplantation without the use of preparative total body irradiation, British Journal of Haematology, vol.98, issue.2, pp.453-460, 1997.
DOI : 10.1046/j.1365-2141.1997.2433060.x

Y. Jung, Y. Jeon, W. Cho, J. Lee, N. Chung et al., Risk factors for short term thyroid dysfunction after hematopoietic stem cell transplantation in children, Korean Journal of Pediatrics, vol.56, issue.7, 2013.
DOI : 10.3345/kjp.2013.56.7.298

J. Orgiazzi, Bull Académie Natl Médecine, pp.43-59, 2013.

M. Aldouri, R. Ruggier, O. Epstein, and H. Prentice, ADOPTIVE TRANSFER OF HYPERTHYROIDISM AND AUTOIMMUNE THYROIDITIS FOLLOWING ALLOGENEIC BONE MARROW TRANSPLANTATION FOR CHRONIC MYELOID LEUKAEMIA, British Journal of Haematology, vol.i, issue.1, pp.118-127, 1990.
DOI : 10.1111/j.1365-2141.1990.00010.x-i1

G. Berisso, M. Van-lint, A. Bacigalupo, and A. Marmont, Adoptive autoimmune hyperthyroidism following allogeneic stem cell transplantation from an HLA-identical sibling with Graves??? disease, Bone Marrow Transplantation, vol.23, issue.10, pp.1091-1093, 1999.
DOI : 10.1038/sj.bmt.1701760

K. Williams, D. Dietzen, A. Hassoun, I. Fennoy, and M. Bhatia, Autoimmune thyroid disease following alemtuzumab therapy and hematopoietic cell transplantation in pediatric patients with sickle cell disease. Pediatr Blood Cancer, pp.2307-2316, 2014.

S. Matthes-martin, A. Lawitschka, G. Fritsch, T. Lion, B. Grimm et al., Stem cell transplantation after reduced-intensity conditioning for sickle cell disease, European Journal of Haematology, vol.59, issue.4, pp.308-320
DOI : 10.1002/pbc.24177

M. Vivanco, J. Dalle, C. Alberti, B. Lescoeur, K. Yakouben et al., Malignant and benign thyroid nodules after total body irradiation preceding hematopoietic cell transplantation during childhood, European Journal of Endocrinology, vol.167, issue.2, pp.225-258, 2012.
DOI : 10.1530/EJE-12-0073

A. Cohen, A. Rovelli, M. Van-lint, F. Merlo, A. Gaiero et al., Secondary thyroid carcinoma after allogeneic bone marrow transplantation during childhood, Bone Marrow Transplantation, vol.28, issue.12, 2001.
DOI : 10.1038/sj.bmt.1703290

S. Mostoufi-moab, K. Seidel, W. Leisenring, G. Armstrong, K. Oeffinger et al., Endocrine Abnormalities in Aging Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study, Journal of Clinical Oncology, vol.34, issue.27, 2016.
DOI : 10.1200/JCO.2016.66.6545

J. Wémeau, J. Sadoul, M. Herbomez, H. Monpeyssen, J. Tramalloni et al., Guidelines of the French society of endocrinology for the management of thyroid nodules, Annales d'Endocrinologie, vol.72, issue.4, pp.251-81, 2011.
DOI : 10.1016/j.ando.2011.05.003

M. Welker and D. Orlov, Thyroid nodules. Am Fam Physician, Feb, vol.167, issue.3, pp.559-66, 2003.

I. Halac and D. Zimmerman, Thyroid Nodules and Cancers in Children, Endocrinology and Metabolism Clinics of North America, vol.34, issue.3, pp.725-769, 2005.
DOI : 10.1016/j.ecl.2005.04.007

D. Dean and H. Gharib, Epidemiology of thyroid nodules, Best Practice & Research Clinical Endocrinology & Metabolism, vol.22, issue.6, pp.901-912, 2008.
DOI : 10.1016/j.beem.2008.09.019

D. Mihailescu and A. Schneider, Size, Number, and Distribution of Thyroid Nodules and the Risk of Malignancy in Radiation-Exposed Patients Who Underwent Surgery, The Journal of Clinical Endocrinology & Metabolism, vol.93, issue.6, pp.2188-93, 2008.
DOI : 10.1210/jc.2008-0055

M. Niedziela and . Pathogenesis, Pathogenesis, diagnosis and management of thyroid nodules in children, Endocrine Related Cancer, vol.13, issue.2, pp.427-53, 2006.
DOI : 10.1677/erc.1.00882

H. Gharib, E. Papini, R. Valcavi, H. Baskin, A. Crescenzi et al., American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules, Endocrine Practice, vol.16, issue.Supplement 1, pp.63-102, 2006.
DOI : 10.4158/10024.GL

M. Rivas and P. Santisteban, TSH-activated signaling pathways in thyroid tumorigenesis, Molecular and Cellular Endocrinology, vol.213, issue.1, pp.31-45, 2003.
DOI : 10.1016/j.mce.2003.10.029

K. Suzuki and S. Yamashita, Low-dose Radiation Exposure and Carcinogenesis, Japanese Journal of Clinical Oncology, vol.42, issue.7, 2012.
DOI : 10.1093/jjco/hys078

R. Elisei, C. Romei, T. Vorontsova, B. Cosci, V. Veremeychik et al., RET/PTC Rearrangements in Thyroid Nodules: Studies in Irradiated and Not Irradiated, Malignant and Benign Thyroid Lesions in Children and Adults, Journal of Clinical Endocrinology & Metabolism, vol.86, issue.7, pp.3211-3217, 2001.
DOI : 10.1210/jc.86.7.3211

A. Bounacer, R. Wicker, M. Schlumberger, A. Sarasin, and H. Suárez, Oncogenic rearrangements of the ret proto-oncogene in thyroid tumors induced after exposure to ionizing radiation, Biochimie, vol.79, issue.9-10, pp.9-10619, 1997.
DOI : 10.1016/S0300-9084(97)82012-3

G. Wilson and R. Curry, Subclinical thyroid disease, Am Fam Physician Oct, vol.1572, issue.8, pp.1517-1541, 2005.

B. Biondi, Natural history, diagnosis and management of subclinical thyroid dysfunction, Best Practice & Research Clinical Endocrinology & Metabolism, vol.26, issue.4, pp.431-477
DOI : 10.1016/j.beem.2011.12.004

F. Al-fiar, R. Colwill, J. Lipton, G. Fyles, D. Spaner et al., Abnormal thyroid stimulating hormone (TSH) levels in adults following allogeneic bone marrow transplants, Bone Marrow Transplantation, vol.19, issue.10, pp.1019-1041, 1997.
DOI : 10.1038/sj.bmt.1700771

B. Borgström and P. Bolme, Thyroid function in children after allogeneic bone marrow transplantation, Bone Marrow Transplant, vol.13, issue.1, pp.59-64, 1994.

H. Ishiguro, Y. Yasuda, Y. Tomita, T. Shinagawa, T. Shimizu et al., Long-Term Follow-Up of Thyroid Function in Patients Who Received Bone Marrow Transplantation during Childhood and Adolescence, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.12, pp.5981-5987, 2004.
DOI : 10.1210/jc.2004-0836

S. Sherman, Thyroid carcinoma. Lancet Lond Engl, Feb, vol.8361, issue.9356, pp.501-512, 2003.

M. Bhatia, J. Z. Baker, C. Geyer, M. Radhakrishnan, K. Morris et al., Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease, Bone Marrow Transplantation, vol.2, issue.7, pp.913-933
DOI : 10.1111/bjh.12413

A. King, N. Kamani, N. Bunin, I. Sahdev, J. Brochstein et al., Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies, American Journal of Hematology, vol.118, issue.12, pp.1093-1101, 2015.
DOI : 10.1182/blood-2011-01-332510

B. Alter, Cancer in Fanconi anemia, 1927-2001, Cancer, vol.10, issue.2, pp.425-465, 2003.
DOI : 10.1038/bjc.1996.354

A. Petryk, K. Shankar, R. Giri, N. Hollenberg, A. Rutter et al., Endocrine Disorders in Fanconi Anemia: Recommendations for Screening and Treatment, The Journal of Clinical Endocrinology & Metabolism, vol.100, issue.3, pp.803-814
DOI : 10.1210/jc.2014-4357

S. Rose, K. Myers, M. Rutter, R. Mueller, J. Khoury et al., Endocrine phenotype of children and adults with Fanconi anemia. Pediatr Blood Cancer, pp.690-696, 2012.

N. Giri, D. Batista, B. Alter, and C. Stratakis, Endocrine Abnormalities in Patients with Fanconi Anemia, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.7, pp.2624-2655, 2007.
DOI : 10.1210/jc.2007-0135

P. Rosenberg, G. Socié, B. Alter, and E. Gluckman, Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants, Blood, vol.105, issue.1, pp.67-73, 2005.
DOI : 10.1182/blood-2004-04-1652

C. Bonfim, L. Ribeiro, S. Nichele, M. Bitencourt, G. Loth et al., Long-term Survival, Organ Function, and Malignancy after Hematopoietic Stem Cell Transplantation for Fanconi Anemia, Biology of Blood and Marrow Transplantation, vol.22, issue.7, pp.1257-63
DOI : 10.1016/j.bbmt.2016.03.007

R. Peffault-de-latour, R. Porcher, J. Dalle, M. Aljurf, E. Korthof et al., Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience, Blood, vol.122, issue.26, pp.4279-86, 2013.
DOI : 10.1182/blood-2013-01-479733

A. Panasiuk, S. Nussey, P. Veys, P. Amrolia, K. Rao et al., Gonadal function and fertility after stem cell transplantation in childhood: comparison of a reduced intensity conditioning regimen containing melphalan with a myeloablative regimen containing busulfan, British Journal of Haematology, vol.30, issue.5
DOI : 10.1200/JCO.2011.35.0504

E. Assouline, R. Crocchiolo, T. Prebet, F. Broussais, D. Coso et al., Impact of reducedintensity conditioning allogeneic stem cell transplantation on women's fertility. Clin Lymphoma Myeloma Leuk, pp.704-714, 2013.

G. Wiedemann, L. Jonetz-mentzel, and R. Panse, Establishment of Reference Ranges for Thyrotropin, Triiodothyronine, Thyroxine and Free Thyroxine in Neonates, Infants, Children and Adolescents, Clinical Chemistry and Laboratory Medicine, vol.31, issue.5
DOI : 10.1055/s-2007-1025411

E. Chaler, R. Fiorenzano, C. Chilelli, V. Llinares, G. Areny et al., Age-specific thyroid hormone and thyrotropin reference intervals for a pediatric and adolescent population, Clinical Chemistry and Laboratory Medicine, vol.50, issue.5, pp.885-90, 2012.
DOI : 10.1515/cclm-2011-0495

M. Elmlinger, W. Kühnel, H. Lambrecht, and M. Ranke, Reference Intervals from Birth to Adulthood for Serum Thyroxine (T4), Triiodothyronine (T3), free T3, free T4, Thyroxine Binding Globulin (TBG) and Thyrotropin (TSH), Clinical Chemistry and Laboratory Medicine, vol.82, issue.10, pp.973-982, 2001.
DOI : 10.1055/s-0028-1093482

N. Majhail, D. Rizzo, J. Lee, S. Aljurf, M. Atsuta et al., Recommended Screening and Preventive Practices for Long-Term Survivors after Hematopoietic Cell Transplantation, Hematol Oncol Stem Cell Ther. 2012, vol.5, issue.1, pp.1-30